Crosspovidone Food Grade E1202 Clarify Beer and Beverage

Name: Crosspovidone Food Grade E1202 Clarify Beer and Beverage
Brand: Shanghai Dexiang Medicine Tech. Co., Ltd.
SKU: 2105892485

Shanghai, ChinaShanghai Dexiang Medicine Tech. Co., Ltd.

Negotiable

100 kgs

Sample price:US$0.01/bag.Request sample

Product profile

CAS No.

25249-54-1

Formula

C6h9no

Resource

Polymerization

Model NO.

DX-PVPP

Purity

95%

Appearance

White Powder

Inci/Ctfa

Insoluble Pvp

Mf

[C6h9no)N

Transport Package

20kgs/Drum

Specification

Bp/Ep/Usp

Trademark

Origin

China

HS Code

39059900

Production Capacity

1800mt/Year

Company profile

Shanghai Dexiang Medicine Tech. Co., Ltd.

Shanghai, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2007-08-03Nearest Port: shanghaiAverage Response Time: ≤15hTerms of Payment: LC, T/T, D/PInternational Commercial Terms(Incoterms): FOB, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryThe supplier is identified as a trading company and limited company, with a stated scope covering chemical raw materials, pharmaceutical intermediates, hardware, and other products. It offers ODM and multiple customization modes, but does not provide 3D software design, SDKs, or OEM services for popular brands. Production information states PVP output of 6,000 tons, while the supplier has only one R&D engineer and launched no new products in the past year. Service procedures for corrective actions, complaint handling, supplier assessment, and quotations are documented, but quality assurance status and raw-material traceability are unknown. The supplier reports exports to more than 30 countries and export sales of 41%–50%, but provides no overseas showroom, agents, branches, or offline trade-show participation. Financial credibility cannot be assessed from the available non-financial evidence.

Supplier typeThe supplier is explicitly classified as a trading company and limited company. Its stated business scope includes technical development and consultation for medicine and chemical raw materials, pharmaceutical intermediates, and sales of multiple product categories, indicating a broad trading and technical-services profile rather than a clearly documented manufacturing-only profile.

After-Sales capabilityThe supplier has clear procedures and followed records for corrective and preventive actions and customer complaints, and its company description claims complete after-sale service. However, it has no overseas showroom, agents, branches, or prior offline trade-show participation, limiting evidence of local overseas support.

R&D capabilityThe supplier provides ODM services and has one R&D engineer, but it launched no new products in the past year, has no available SDK, and does not provide 3D software design services. The evidence supports limited innovation resources rather than a demonstrated strong innovation record.

Customization capabilityThe supplier explicitly supports customization from samples, designs, full customization, and minor customization, and also provides ODM services. These multiple documented customization modes indicate a clear customization capability, despite the absence of 3D software design and SDK support.

Client casesThe company states that some products have been sold to more than 30 countries and areas across Europe, Asia, Africa, North America, and South America, and export sales are reported at 41%–50% of total sales. No named customers or specific project cases are provided, so the evidence demonstrates geographic market experience rather than verifiable named customer cases.